本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Kymera Therapeutics, Inc.

25.97
+0.95003.80%
盤後25.970.00000.00%16:35 EDT
成交量:46.88萬
成交額:1,199.72萬
市值:16.87億
市盈率:-8.71
高:26.03
開:25.00
低:24.72
收:25.02
資料載入中...
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/11

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/10

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/05

重要事件披露

Form 8-K - Current report
2024/01/04

重要事件披露

Form 8-K - Current report
2024/01/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/04

重要事件披露

Form 8-K - Current report
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/03

重要事件披露

Form 8-K - Current report
2023/06/16

重要事件披露

Form 8-K - Current report
2023/06/05

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/23

重要事件披露

Form 8-K - Current report
2023/05/04

重要事件披露

8-K - Current report